Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Sanofi develops novel DGAT1 inhibitors for metabolic disorders

April 12, 2013

Potential new treatment for patients susceptible to lactic acidosis

April 12, 2013

Dosing begins in phase II trial of ATL-1103 for the treatment of acromegaly

April 11, 2013

Daiichi Sankyo discloses new DGAT1 inhibitors

April 11, 2013

Encouraging phase I study results reported for LPCN-1111

April 10, 2013

DiaMedica cleared to conduct trial of lead diabetes treatment candidate

April 9, 2013

Roche presents new aldosterone synthase inhibitors

April 9, 2013

Sanofi designs novel PKC-beta inhibitors

April 9, 2013

ELOVL6 inhibitors suitable for treating insulin resistance

April 9, 2013

Uncovering the antioxidative potential of paroxetine in hyperglycemic conditions

April 9, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...